Editor’s Highlight: Pulmonary Vascular Thrombosis in Rats Exposed to Inhaled Sulfur Mustard

Sulfur mustard (SM) is a chemical warfare agent. When inhaled, SM causes significant injury to the respiratory tract. Although the mechanism involved in acute airway injury after SM inhalation has been well described previously, the mechanism of SM's contribution to distal lung vascular injury is not well understood. We hypothesized that acute inhalation of vaporized SM causes activated systemic coagulation with subsequent pulmonary vascular thrombi formation after SM inhalation exposure. Sprague Dawley rats inhaled SM ethanolic vapor (3.8 mg/kg). Barium/gelatin CT pulmonary angiograms were performed to assess for pulmonary vascular thrombi burden. Lung immunohistochemistry was performed for common procoagulant markers including fibrin(ogen), von Willebrand factor, and CD42d in control and SM-exposed lungs. Additionally, systemic levels of d-dimer and platelet aggregometry after adenosine diphosphate- and thrombin-stimulation were measured in plasma after SM exposure. In SM-exposed lungs, chest CT angiography demonstrated a significant decrease in the distal pulmonary vessel density assessed at 6 h postexposure. Immunohistochemistry also demonstrated increased intravascular fibrin(ogen), vascular von Willebrand factor, and platelet CD42d in the distal pulmonary vessels (<200 µm diameter). Circulating d-dimer levels were significantly increased (p < .001) at 6, 9, and 12 h after SM inhalation versus controls. Platelet aggregation was also increased in both adenosine diphosphate - (p < .01) and thrombin- (p < .001) stimulated platelet-rich plasma after SM inhalation. Significant pulmonary vascular thrombi formation was evident in distal pulmonary arterioles following SM inhalation in rats assessed by CT angiography and immunohistochemistry. Enhanced systemic platelet aggregation and activated systemic coagulation with subsequent thrombi formation likely contributed to pulmonary vessel occlusion.

[1]  G. Hansmann,et al.  Cardiac MR and CT imaging in children with suspected or confirmed pulmonary hypertension/pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by IS , 2016, Heart.

[2]  T. Vu,et al.  VEGF and endothelium-derived retinoic acid regulate lung vascular and alveolar development. , 2016, American journal of physiology. Lung cellular and molecular physiology.

[3]  Meng Li,et al.  Image quality evaluation of iterative model reconstruction on low tube voltage (80 kVp) coronary CT angiography in an animal study , 2016, Acta Radiologica.

[4]  T. Struffert,et al.  Influence of different reconstruction parameters in the visualization of intracranial stents using C-arm flat panel CT angiography: experience in an animal model , 2016, Acta radiologica.

[5]  D. Kiely,et al.  Response to: ‘CT assessment for pulmonary hypertension requires systematic assessment of cardiac, vascular and parenchymal signs’ by Marloes et al , 2015, Thorax.

[6]  S. Jayathissa,et al.  Investigation of Suspected Pulmonary Embolism at Hutt Valley Hospital with CT Pulmonary Angiography: Current Practice and Opportunities for Improvement , 2015, Advances in medicine.

[7]  R. Rancourt,et al.  Airway tissue plasminogen activator prevents acute mortality due to lethal sulfur mustard inhalation. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  R. Rancourt,et al.  Antifibrinolytic mechanisms in acute airway injury after sulfur mustard analog inhalation. , 2014, American journal of respiratory cell and molecular biology.

[9]  Y. Siegel,et al.  Pulmonary Hypertension Detection Using Dynamic and Static Measurable Parameters on CT Angiography , 2014, Journal of computer assisted tomography.

[10]  R. Rancourt,et al.  Tissue factor pathway inhibitor prevents airway obstruction, respiratory failure and death due to sulfur mustard analog inhalation. , 2013, Toxicology and applied pharmacology.

[11]  M. Ghanei,et al.  Isolated bronchiolitis obliterans: high incidence and diagnosis following terrorist attacks , 2012, Inhalation toxicology.

[12]  P. Ray,et al.  Pathological Studies on the Protective Effect of a Macrolide Antibiotic, Roxithromycin, against Sulfur Mustard Inhalation Toxicity in a Rat Model , 2011, Toxicologic pathology.

[13]  R. Rancourt,et al.  Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation. , 2010, American journal of respiratory and critical care medicine.

[14]  C. Simbulan-Rosenthal,et al.  Sulfur mustard induces apoptosis in lung epithelial cells via a caspase amplification loop. , 2010, Toxicology.

[15]  M. Ghanei,et al.  Noninvasive diagnosis of bronchiolitis obliterans due to sulfur mustard exposure: could high-resolution computed tomography give us a clue? , 2010, La radiologia medica.

[16]  Gary R. Grotendorst,et al.  Inhalation exposure systems for the development of rodent models of sulfur mustard-induced pulmonary injury , 2010, Toxicology mechanisms and methods.

[17]  Robert C. Molthen,et al.  Automation process for morphometric analysis of volumetric CT data from pulmonary vasculature in rats , 2010, Comput. Methods Programs Biomed..

[18]  K. Kehe,et al.  Acute effects of sulfur mustard injury--Munich experiences. , 2009, Toxicology.

[19]  K. Kehe,et al.  The chronic effects of sulfur mustard exposure. , 2009, Toxicology.

[20]  C. White,et al.  A Role for Mitochondrial Oxidative Stress in Sulfur Mustard Analog 2-Chloroethyl Ethyl Sulfide-Induced Lung Cell Injury and Antioxidant Protection , 2009, Journal of Pharmacology and Experimental Therapeutics.

[21]  M. Wattana,et al.  Mustard Gas or Sulfur Mustard: An Old Chemical Agent as a New Terrorist Threat , 2009, Prehospital and Disaster Medicine.

[22]  M. Chilosi,et al.  An international collaborative pathologic study of surgical lung biopsies from mustard gas-exposed patients. , 2008, Respiratory medicine.

[23]  S. Mousavi,et al.  Chronic health effects of sulphur mustard exposure with special reference to Iranian veterans. , 2008 .

[24]  Ehsan Samei,et al.  Tomographic digital subtraction angiography for lung perfusion estimation in rodents. , 2007, Medical physics.

[25]  W. Bloch,et al.  Assessment of Alterations in Barrier Functionality and Induction of Proinflammatory and Cytotoxic Effects After Sulfur Mustard Exposure of an In Vitro Coculture Model of the Human Alveolo-Capillary Barrier , 2007, Inhalation toxicology.

[26]  Ali Emad,et al.  Levels of cytokine in bronchoalveolar lavage (BAL) fluid in patients with pulmonary fibrosis due to sulfur mustard gas inhalation. , 2007, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[27]  T. Neff,et al.  Attenuation of half sulfur mustard gas‐induced acute lung injury in rats , 2006, Journal of applied toxicology : JAT.

[28]  K. Vesely,et al.  Treatment of sulfur mustard (HD)‐induced lung injury † , 2000, Journal of applied toxicology : JAT.

[29]  R. Vijayaraghavan,et al.  Histomorphological and histochemical alterations following short-term inhalation exposure to sulfur mustard on visceral organs of mice. , 1999, Biomedical and environmental sciences : BES.

[30]  D. A. Luke,et al.  Computerized morphometry of the pulmonary vasculature over a range of intravascular pressures , 1998, The Anatomical record.

[31]  A. Bankier,et al.  [Spiral CT angiography in diagnosis of acute pulmonary embolism. What factors modify implementation of standard algorithms?]. , 1998, Der Radiologe.

[32]  D. Mitchell,et al.  Mustard gas casualties , 1991, The Lancet.

[33]  A. Newman-Taylor,et al.  Experience with mustard gas casualties , 1991, The Lancet.